MAPK9 and cardiac arrhythmia: Our recent findings are significant because these JNK2-specific actions on CaMKIIδ activity and SR Ca2+ mishandling shed new light on modulating JNK2 as a new strategy to target CaMKIIδ activity for preventing and treating arrhythmias.